Skip to main content
Caplight Logo









Noraker

Noraker

Private
LyonHealthcare & Life Scienceshttps://noraker.com/en

Last Round

Grant

Feb 17, 2022

Total Funding Raised

$5.28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Noraker operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Grant round in February 2022.

Noraker is a medical devices company that specializes in the design, manufacturing, and marketing of biomaterial-based implants for bone regeneration and osteosynthesis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Noraker Comparables

Compare Noraker with similar companies based on industry and business-model similarity.

Noraker comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BonAlive Biomaterials
89%
Hydrumedical S.A.
86%
Synergy Biomedical, LLC
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Noraker Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2022
GrantNov 1, 2019
SeedDec 1, 2007
Early FundingDec 1, 2006
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Celine Saint Olive

CEO

Executive Team

For institutional investors. Book with your work email.

Noraker Investors

Notable investors and investment history

Noraker investors
InvestorRounds
European CommissionGrant
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 370% MoM, reaching 969.

  • Feb 21, 2026

    Grew 27% QoQ, from 30 to 38 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Noraker Filings

Explore SEC and related filing metadata, where available.

Noraker filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Noraker's valuation, stock price, and market status.

Is Noraker a public or private company?

Noraker is a private company.

What is the current stock price of Noraker?

Noraker is a private company, so its shares have no public market price. Caplight tracks Noraker's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Noraker worth (valuation)?

Valuation information for Noraker is not publicly available.

Can I buy Noraker stock?

Noraker shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Noraker's last funding round?

Noraker's most recent funding round was Grant on February 17, 2022.

Who are the main investors in Noraker?

Key investors in Noraker include European Commission, Bpifrance.

Will Noraker IPO soon?

No public IPO plans have been announced for Noraker.

How can I track Noraker secondary market activity?

Caplight tracks bids, offers, and trades in Noraker's shares on secondary markets.

Firmographic Details

HeadquartersLyon
Employee Range32
Year Founded2005
Last FundingFeb 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?